189 related articles for article (PubMed ID: 31281892)
1. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation.
Lee YS; Riopel M; Cabrales P; Bandyopadhyay GK
Sci Adv; 2019 Jul; 5(7):eaaw4176. PubMed ID: 31281892
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
[TBL] [Abstract][Full Text] [Related]
3. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
5. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity.
Danilova OV; Tai AK; Mele DA; Beinborn M; Leiter AB; Greenberg AS; Perfield JW; Defuria J; Singru PS; Lechan RM; Huber BT
Endocrinology; 2009 Dec; 150(12):5240-8. PubMed ID: 19819973
[TBL] [Abstract][Full Text] [Related]
6. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.
Ben-Shlomo S; Zvibel I; Shnell M; Shlomai A; Chepurko E; Halpern Z; Barzilai N; Oren R; Fishman S
J Hepatol; 2011 Jun; 54(6):1214-23. PubMed ID: 21145820
[TBL] [Abstract][Full Text] [Related]
8. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis.
Ben-Shlomo S; Zvibel I; Rabinowich L; Goldiner I; Shlomai A; Santo EM; Halpern Z; Oren R; Fishman S
Dig Dis Sci; 2013 Jan; 58(1):172-8. PubMed ID: 22918684
[TBL] [Abstract][Full Text] [Related]
10. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
13. Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation.
Kihira Y; Miyake M; Hirata M; Hoshina Y; Kato K; Shirakawa H; Sakaue H; Yamano N; Izawa-Ishizawa Y; Ishizawa K; Ikeda Y; Tsuchiya K; Tamaki T; Tomita S
PLoS One; 2014; 9(4):e93856. PubMed ID: 24705496
[TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
[TBL] [Abstract][Full Text] [Related]
15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression.
Trzaskalski NA; Vulesevic B; Nguyen MA; Jeraj N; Fadzeyeva E; Morrow NM; Locatelli CA; Travis N; Hanson AA; Nunes JR; O'Dwyer C; van der Veen JN; Lorenzen-Schmidt I; Seymour R; Pulente SM; Clément AC; Crawley AM; Jacobs RL; Doyle MA; Cooper CL; Kim KH; Fullerton MD; Mulvihill EE
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36472923
[TBL] [Abstract][Full Text] [Related]
17. Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells.
Mooli RGR; Mukhi D; Pasupulati AK; Evers SS; Sipula IJ; Jurczak M; Seeley RJ; Shah YM; Ramakrishnan SK
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1057-1072. PubMed ID: 34902628
[TBL] [Abstract][Full Text] [Related]
18. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.
Baumeier C; Schlüter L; Saussenthaler S; Laeger T; Rödiger M; Alaze SA; Fritsche L; Häring HU; Stefan N; Fritsche A; Schwenk RW; Schürmann A
Mol Metab; 2017 Oct; 6(10):1254-1263. PubMed ID: 29031724
[TBL] [Abstract][Full Text] [Related]
19. Disruption of HIF-1α in hepatocytes impairs glucose metabolism in diet-induced obesity mice.
Ochiai D; Goda N; Hishiki T; Kanai M; Senoo-Matsuda N; Soga T; Johnson RS; Yoshimura Y; Suematsu M
Biochem Biophys Res Commun; 2011 Nov; 415(3):445-9. PubMed ID: 22051049
[TBL] [Abstract][Full Text] [Related]
20. The Role of High Fat Diets and Liver Peptidase Activity in the Development of Obesity and Insulin Resistance in Wistar Rats.
Domínguez-Vías G; Segarra AB; Ramírez-Sánchez M; Prieto I
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
